Gideon Spanier
Mar 21, 2019

GSK hikes online spend due to 'higher return' than TV

Google partnership led to 74% improvement in ad impressions.

GSK hikes online spend due to 'higher return' than TV

GlaxoSmithKline "significantly" increased its advertising spend in online media last year because it is delivering a "far higher return" than traditional TV.

The pharmaceuticals giant told shareholders it has been investing in digital and ecommerce capabilities and saw a 74% increase in digital media impressions from the same investment, thanks to a partnership with Google.

GSK, owner of brands such as Panadol, Sensodyne, Corsodyl and Voltarol, spent £1.38 billion (US$1.82 billion) on advertising last year, up slightly from £1.35 billion (US$1.79 billion) in 2017, according to the annual report.

"By putting digital technology at the heart of our business, we aim to deliver more meaningful interactions with consumers, fuel brand growth and achieve efficiency savings," the report said.

"Reflecting the far higher return on online media, compared with traditional television advertising, we significantly increased the digital balance of our marketing."

The FTSE-100 company added that it has struck deals with tech companies, including Google and Alimama, the marketing arm of Alibaba.

"Our partnership with Google has driven greater efficiency in our media targeting," the report said. "We drove 4.5 billion more viewable digital media impressions than the same investment would have generated in 2017, representing a 74% increase."

GSK has also launched a Marketing IQ development programme for 1,300 of its marketing staff and set up a digital advisory board, made up of external advisers, "to challenge our thinking and help shape our digital strategy".

GSK consolidated its global media buying account with one agency group, Publicis Media, last year after a hard-fought review that ended with GSK negotiating with four agencies over four days in Twickenham Stadium in London.

Blue 449 and Digitas handle media duties in the UK as part of a bespoke "platformGSK" model, which includes healthcare, consumer strategy and digital business transformation.

Emma Walmsley, a former L’Oréal marketer, has been chief executive of GSK since 2017.

She has announced plans to merge its consumer healthcare arm with Pfizer’s consumer division in a joint venture

Source:
Campaign UK

Related Articles

Just Published

4 hours ago

Agency Report Card 2024: Mindshare

Mindshare faced significant setbacks in APAC in 2024, losing nearly a billion dollars in client business and falling out of Campaign's top 20 rankings, highlighting the need for strategic renewal.

5 hours ago

2025 Cannes Contenders: Dentsu APAC leaders place ...

From the grippingly serious to the hilariously eccentric, three Dentsu creative and product leaders across APAC give their nods to award-worthy work that may win a Cannes Lions next week.

6 hours ago

'Media isn’t a commodity. Treating it like one is a ...

Ruben Schreurs tells Campaign why litigation, platform volatility, and outdated media models are distorting decision-making—and why advertisers need to focus less on adjacency panic, and more on strategic clarity.

7 hours ago

WPP never seized control of its destiny under Mark ...

Departing CEO had some notable successes, but the company has struggled.